Article Information
History
- March 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Viet-Thi Tran1,2,*,
- Caroline Riveros1,2,
- Bérangère Clepier3,
- Moïse Desvarieux1,4,
- Camille Collet3,
- Youri Yordanov5,6 and
- Philippe Ravaud1,2,4
- 1Université de Paris, CRESS, INSERM, INRA, F-75004 Paris, France
- 2Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, 75004 Paris, France
- 3Patient, France
- 4Department of Epidemiology, Columbia University Mailman School of Public Health, 22 W 168th St, New York, NY, USA
- 5Service d’Accueil des Urgences, Hôpital Saint Antoine, AP-HP, Sorbonne Université, Paris, France
- 6INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, UMR-S 1136, Paris, France
- ↵*Correspondence to:
Viet-Thi Tran - MD, PhD, Hôpital Hôtel Dieu, Centre d’Épidémiologie Clinique, Paris, France, 1 place du Parvis Notre-Dame, Paris 75181, France, Tel: +33 1 42 34 89 87, fax: +33 1 42 34 87 90, email: thi.tran-viet{at}aphp.fr
Posted March 20, 2021.
Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients’ lived experience
